Customize your JAMA Network experience by selecting one or more topics from the list below.
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common childhood disorders, affecting an estimated 11% of boys and 4% of girls in the United States.1 Stimulant medications manage ADHD symptoms in most children.2,3 However, many parents prefer that treatment include some nonpharmacologic therapy,4,5 and combination behavioral therapy and pharmacotherapy may improve outcomes over either modality alone for many youth.3,6
Little is known about what proportion of children treated with ADHD medication also receive nonpharmacologic therapy (hereafter referred to as therapy) and how rates of combination therapy vary geographically. We used a large commercial claims database (MarketScan) linked to county-level information on the supply of psychologists to examine variation in receipt of therapy in children receiving ADHD medication.
Gellad WF, Stein BD, Ruder T, et al. Geographic Variation in Receipt of Psychotherapy in Children Receiving Attention-Deficit/Hyperactivity Disorder Medications. JAMA Pediatr. 2014;168(11):1074–1076. doi:10.1001/jamapediatrics.2014.1647
Create a personal account or sign in to: